Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilfried Posch

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Frontiers in Microbiology|August 7, 2018
The Evolutionary Conserved γ-Core Motif Influences the Anti-<i>Candida</i> Activity of the <i>Penicillium chrysogenum</i> Antifungal Protein PAFChristoph Sonderegger, Györgyi Váradi, László Galgóczy, et al.
Virologica Sinica|March 12, 2022
The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitroSissy Therese Sonnleitner, Stefanie Sonnleitner, Eva Hinterbichler, et al.
Journal of Fungi (Basel, Switzerland)|February 25, 2022
COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal SusceptibilityNina Lackner, Claudius Thomé, Dietmar Öfner, et al.
Frontiers in Immunology|May 31, 2023
Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variantsSissy Therese Sonnleitner, Samira Walder, Ludwig Knabl, et al.
Respiratory Research|March 23, 2023
GlyPerA™ effectively shields airway epithelia from SARS-CoV-2 infection and inflammatory eventsViktoria Zaderer, Stefanie Dichtl, Wilfried Posch, et al.
Infection and Immunity|May 22, 2013
Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cellsSilvia Ehrlenbach, Alejandra Rosales, Wilfried Posch, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2025
Aloe-derived polysaccharides (APS) mitigate SARS-CoV-2 Omicron BQ1.1 infection by preserving epithelial integrity and reducing viral load in human airway epithelial (HAE) culturesWilfried Posch, Ekambaranellore Prakash, Sophie Ann Erckert, et al.
Frontiers in Immunology|September 14, 2020
CR4 Signaling Contributes to a DC-Driven Enhanced Immune Response Against Complement-Opsonized HIV-1Marta Bermejo-Jambrina, Michael Blatzer, Paula Jauregui-Onieva, et al.
Frontiers in Medicine|October 17, 2022
Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infectionsStefanie Dichtl, Viktoria Zaderer, Viktoria Kozubowski, et al.
Frontiers in Immunology|June 11, 2019
Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory CapacityManuela Schönfeld, Ulla Knackmuss, Parul Chandorkar, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Frontiers in Microbiology|August 7, 2018
The Evolutionary Conserved γ-Core Motif Influences the Anti-<i>Candida</i> Activity of the <i>Penicillium chrysogenum</i> Antifungal Protein PAFChristoph Sonderegger, Györgyi Váradi, László Galgóczy, et al.
Virologica Sinica|March 12, 2022
The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitroSissy Therese Sonnleitner, Stefanie Sonnleitner, Eva Hinterbichler, et al.
Journal of Fungi (Basel, Switzerland)|February 25, 2022
COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal SusceptibilityNina Lackner, Claudius Thomé, Dietmar Öfner, et al.
Frontiers in Immunology|May 31, 2023
Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variantsSissy Therese Sonnleitner, Samira Walder, Ludwig Knabl, et al.
Respiratory Research|March 23, 2023
GlyPerA™ effectively shields airway epithelia from SARS-CoV-2 infection and inflammatory eventsViktoria Zaderer, Stefanie Dichtl, Wilfried Posch, et al.
Infection and Immunity|May 22, 2013
Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cellsSilvia Ehrlenbach, Alejandra Rosales, Wilfried Posch, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2025
Aloe-derived polysaccharides (APS) mitigate SARS-CoV-2 Omicron BQ1.1 infection by preserving epithelial integrity and reducing viral load in human airway epithelial (HAE) culturesWilfried Posch, Ekambaranellore Prakash, Sophie Ann Erckert, et al.
Frontiers in Immunology|September 14, 2020
CR4 Signaling Contributes to a DC-Driven Enhanced Immune Response Against Complement-Opsonized HIV-1Marta Bermejo-Jambrina, Michael Blatzer, Paula Jauregui-Onieva, et al.
Frontiers in Medicine|October 17, 2022
Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infectionsStefanie Dichtl, Viktoria Zaderer, Viktoria Kozubowski, et al.
Frontiers in Immunology|June 11, 2019
Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory CapacityManuela Schönfeld, Ulla Knackmuss, Parul Chandorkar, et al.
Pageof 9